| Ethyl 2-[3-chloro-5-(trifluoromethyl)-2-pyridyl]-2-cyanoacetate |
2-[3-氯-5-(三氟甲基)吡啶-2-基]-2-氰基乙酸乙酯 |
923251-81-4 |
| 4-Pentenoicacid,2-acetyl-4-methyl-,ethyl |
2-乙酰基-4-甲基-4-戊烯酸乙酯 |
20962-70-3 |
| AZD5991 |
AZD5991 |
2143010-83-5 |
| BAY707) |
BAY707) |
2109805-96-9 |
| 2(1H)-Pyridinone, 3-[5-[(5-chloro-2-pyridinyl)methyl]-1,3,4-oxadiazol-2-yl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy- |
BMS-986224 |
2055200-88-7 |
| 9α-BroMo-16α-Methylprednisolone |
9α-BroMo-16α-Methylprednisolone |
26543-61-3 |
| GDC0276 |
GDC0276 |
1494581-70-2 |
| Intermediate |
1429558-08-6 |
1429558-08-6 |
| (5-aMino-2-butyl-1-benzofuran-3-yl)(4-hydroxyphenyl)Methanone |
决奈达隆杂质 |
1278585-68-4 |
| Gepotidacin |
1075236-89-3 |
1075236-89-3 |
| Bifenazate oxidation type |
联苯肼酯相关物 |
149878-40-0 |
| alpha-hydroxyfuran-2-acetic acid |
1-(呋喃-2-基)-2,2-二羟基乙酮 |
19377-73-2 |
| 6-aminotetralin-2,3-diol |
6-aminotetralin-2,3-diol |
13575-86-5 |
| PF-06273340 |
N-[5-[2-AMINO-7-(1-HYDROXY-2-METHYLPROPAN-2-YL)PYRROLO[2,3-D]PYRIMIDINE-5-CARBONYL]PYRIDIN-3-YL]-2-(5-CHLOROPYRIDIN-2-YL)ACETAMIDE |
1402438-74-7 |
| 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 11,21-diacetate |
9-氟-11BETA,17,21-三羟基-16ALPHA-甲基孕甾-1,4-二烯-3,20-二酮 11,21-二乙酸酯 |
3949-26-6 |
| UNC-2371A |
1429882-07-4 |
1429882-07-4 |
| 5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one |
BGB-TG-P1 |
1446090-77-2 |
| GSK-LSD1 |
GSK-LSD1 |
1431368-48-7 |
| 7-methoxy-2,2-dimethylchroman-6-yl palmitate |
二甲基甲氧基苯并二氢吡喃棕榈酸酯(吡喃美白剂) |
1105025-85-1 |
| Deruxtecan |
德鲁替康 |
1599440-13-7 |
QQ
微信
